Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
UCB Japan Co. Ltd.
Age
16–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subject is a male or female aged ≥ 16 years
Subject has Partial Onset Seizures that are classifiable according to the 1981 International League Against Epilepsy (ILAE) classification of Epileptic Seizures
Subject weighs ≥ 40 kg
Subject is currently taking Levetiracetam (LEV) as an adjunctive antiepileptic oral treatment with 1 to 3 other Antiepileptic Drugs (AEDs)
You may not be if
Subject has problems with venous accessibility
Subject has participated in another clinical/pharmacological study during the last 4 weeks prior to the Screening Visit
Subject is pregnant or lactating
Subject has a history of suicide attempt(s) or presents with current depressive signs, current suicidal ideation, and/or behavior
Subject has clinically significant Electrocardiogram (ECG) abnormalities according to the investigator
